SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/6D0C4397701D4ABB643ED7824A6B8FECA9AE717F6AB5D2A3020C8EB5B8F20DFE22D8D4B50DB48E1B54CCFFDE08D6922B>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/6D0C4397701D4ABB643ED7824A6B8FECA9AE717F6AB5D2A3020C8EB5B8F20DFE22D8D4B50DB48E1B54CCFFDE08D6922B
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/6D0C4397701D4ABB643ED7824A6B8FECA9AE717F6AB5D2A3020C8EB5B8F20DFE22D8D4B50DB48E1B54CCFFDE08D6922B
http://www.w3.org/2000/01/rdf-schema#comment
"This study shows GalR3-mediated neuroprotection supporting a potential future therapeutic development based on GalR3 activation for the treatment of brain disorders"
xsd:string
http://purl.uniprot.org/uniprot/#_427A038EA5A6D4AF9FC54E032A708F7668F39A7E2E2EE3B65FD1BBE8A7782FA53AA0E9D48EB0A11CEB07C82C465A0C31
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/6D0C4397701D4ABB643ED7824A6B8FECA9AE717F6AB5D2A3020C8EB5B8F20DFE22D8D4B50DB48E1B54CCFFDE08D6922B
http://purl.uniprot.org/uniprot/O88853
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6D0C4397701D4ABB643ED7824A6B8FECA9AE717F6AB5D2A3020C8EB5B8F20DFE22D8D4B50DB48E1B54CCFFDE08D6922B
http://purl.uniprot.org/uniprot/#_O88853-mappedCitation-23927369
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/6D0C4397701D4ABB643ED7824A6B8FECA9AE717F6AB5D2A3020C8EB5B8F20DFE22D8D4B50DB48E1B54CCFFDE08D6922B